{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T21:32:27Z","timestamp":1750109547043},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,5]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Use of proton-pump inhibitors (PPIs) is suggested to be associated with adverse cardiovascular (CV) events via. endothelial dysfunction. Studies show that PPIs are associated with increased risk of myocardial infarction (MI) among patients with preexisting CV disease. However, little is known about their risk among people without known CV disease.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We conducted a nested case\u2013control study in the UK Clinical Practice Research Datalink (CPRD) GOLD to evaluate the association between PPI use and risk of MI in patients without known CV disease. From among PPIs users age 25 to 65 between 1988 and 2017, we identified 32,793 MI cases and 127,291 controls matched 4:1 on age, sex, general practice setting, and calendar time. Using logistic regression, we calculated odds ratios (ORs) and 95% confidence intervals (CIs) for MI comparing PPI users to nonusers, adjusting for body mass index, smoking, alcohol abuse, drug abuse, type 2 diabetes, hyperlipidemia, hypertension, and peripheral artery disease. We repeated this analysis in users of histamine 2 receptor antagonists (H2RA), a drug with a similar indication, to assess protopathic bias.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The risk of MI was elevated in new users of PPIs with one to five prescriptions (adjusted OR = 2.8; 95% CI = 2.6, 3.0), but not in any other exposure category. The results among H2RA users were similar across all exposure categories, suggesting that protopathic bias likely explains the results.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Our study results were not consistent with the hypothesis that PPI use increases MI risk among people without known heart disease.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ede.0000000000001152","type":"journal-article","created":{"date-parts":[[2019,12,6]],"date-time":"2019-12-06T19:58:23Z","timestamp":1575662303000},"page":"423-431","source":"Crossref","is-referenced-by-count":6,"title":["Proton-pump Inhibitor Use and Myocardial Infarction"],"prefix":"10.1097","volume":"31","author":[{"given":"Yiran","family":"Qian","sequence":"first","affiliation":[{"name":"Boston Collaborative Drug Surveillance Program, Lexington, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Jick","sequence":"additional","affiliation":[{"name":"Boston Collaborative Drug Surveillance Program, Lexington, MA"},{"name":"Department of Epidemiology, Boston University School of Public Health, Boston, MA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R2-20230908","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.ajem.2014.03.019","article-title":"Rising rates of proton pump inhibitor prescribing in US emergency departments.","volume":"32","author":"Mazer-Amirshahi","year":"2014","journal-title":"Am J Emerg Med"},{"key":"R3-20230908","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1001\/jamainternmed.2015.7927","article-title":"Adverse effects associated with proton pump inhibitors.","volume":"176","author":"Schoenfeld","year":"2016","journal-title":"JAMA Intern Med"},{"key":"R5-20230908","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jacc.2007.06.064","article-title":"Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study.","volume":"51","author":"Gilard","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R6-20230908","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/clpt.2010.219","article-title":"Differential effects of omeprazole and pantoprazole on the pharmacodynamics and pharmacokinetics of clopidogrel in healthy subjects: randomized, placebo-controlled, crossover comparison studies.","volume":"89","author":"Angiolillo","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"R9-20230908","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1161\/CIRCULATIONAHA.113.003602","article-title":"Unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine.","volume":"128","author":"Ghebremariam","year":"2013","journal-title":"Circulation"},{"key":"R10-20230908","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1001\/jama.2009.261","article-title":"Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome.","volume":"301","author":"Ho","year":"2009","journal-title":"JAMA"},{"key":"R11-20230908","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMoa1007964","article-title":"Clopidogrel with or without omeprazole in coronary artery disease.","volume":"363","author":"Bhatt","year":"2010","journal-title":"N Engl J Med"},{"key":"R12-20230908","doi-asserted-by":"crossref","first-page":"378","DOI":"10.7326\/0003-4819-153-6-201009210-00005","article-title":"Proton-pump inhibitors are associated with increased cardiovascular risk independent of clopidogrel use: a nationwide cohort study.","volume":"153","author":"Charlot","year":"2010","journal-title":"Ann Intern Med"},{"key":"R13-20230908","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s11239-008-0282-2","article-title":"Early use of omeprazole benefits patients with acute myocardial infarction.","volume":"28","author":"Gao","year":"2009","journal-title":"J Thromb Thrombolysis"},{"key":"R14-20230908","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ijcard.2014.09.036","article-title":"Proton pump inhibitor use represents an independent risk factor for myocardial infarction.","volume":"177","author":"Shih","year":"2014","journal-title":"Int J Cardiol"},{"key":"R15-20230908","doi-asserted-by":"crossref","first-page":"e0124653","DOI":"10.1371\/journal.pone.0124653","article-title":"Proton pump inhibitor usage and the risk of myocardial infarction in the general population.","volume":"10","author":"Shah","year":"2015","journal-title":"PLoS One"},{"key":"R16-20230908","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/ije\/dyv098","article-title":"Data resource profile: Clinical Practice Research Datalink (CPRD).","volume":"44","author":"Herrett","year":"2015","journal-title":"Int J Epidemiol"},{"key":"R17-20230908","first-page":"247","article-title":"The read clinical classification.","volume":"17","author":"Chisholm","year":"1990","journal-title":"Health Bull (Raleigh)"},{"key":"R18-20230908","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0002-9149(99)00322-7","article-title":"Gender differences in symptom presentation associated with coronary heart disease.","volume":"84","author":"Milner","year":"1999","journal-title":"Am J Cardiol"},{"key":"R19-20230908","first-page":"959","article-title":"Diagnostic, prognostic, and cost assessment of coronary artery disease in women.","volume":"7","author":"Merz","year":"2001","journal-title":"Am J Manag Care"},{"key":"R20-20230908","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1161\/01.CIR.0000097116.29625.7C","article-title":"Women\u2019s early warning symptoms of acute myocardial infarction.","volume":"108","author":"McSweeney","year":"2003","journal-title":"Circulation"},{"key":"R21-20230908","doi-asserted-by":"crossref","first-page":"f2350","DOI":"10.1136\/bmj.f2350","article-title":"Completeness and diagnostic validity of recording acute myocardial infarction events in primary care, hospital care, disease registry, and national mortality records: cohort study.","volume":"346","author":"Herrett","year":"2013","journal-title":"BMJ"},{"key":"R22-20230908","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/pds.3926","article-title":"Validation of low-dose aspirin prescription data in The Health Improvement Network: how much misclassification due to over-the-counter use?","volume":"25","author":"Cea Soriano","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"}],"container-title":["Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/EDE.0000000000001152","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T11:31:49Z","timestamp":1694172709000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/EDE.0000000000001152"}},"subtitle":["A Nested Case\u2013Control Study in the UK Clinical Practice Research Datalink"],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/ede.0000000000001152","relation":{},"ISSN":["1044-3983"],"issn-type":[{"value":"1044-3983","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]}}}